A process/medication known as E-MOTIVE, has been shown to dramatically reduce severe bleeding after childbirth. The solution involves objectively measuring blood loss using a simple, low-cost collection device called a ‘drape’ and bundling together WHO-recommended treatments - rather than offering them sequentially.
The study, which involved over 200 000 women in four countries, found that the solution was effective in reducing severe bleeding by 60%. It also resulted in a reduction in the rate of blood transfusions, which is of particular importance in low-income countries where blood is a scarce and expensive resource.
The findings of this study are a major breakthrough in the fight against maternal mortality. Postpartum haemorrhage is the leading cause of maternal death worldwide, and this solution has the potential to save millions of lives.
The E-MOTIVE solution is now being rolled out in countries around the world, and it is expected to have a major impact on the prevention of maternal mortality.
